S_mmary Congenital hypertrophy of the retinal pigment epithelium (CHRPE) and multiple mandibular osteomata are markers of familial adenomatous polyposis (FAP). We have assessed their prevalence in non-polyposis familial colorectal neoplasia. Multiple mandibular osteomata were present in 1 29 (3%) patients with familial colorectal neoplasia. CHRPE was present in 11 33 (33%) patients with familial colorectal neoplasia compared with 3 36 (8%) with sporadic disease (P = 0.01) and 4 32 (12.5%) control subjects (P = 0.04). Seven patients with familial colorectal neoplasia had multiple areas of CHRPE compared with one with sporadic disease (P = 0.02) and one control subject (P = Berk et al., 1988; Chapman et al., 1989; Burn et al.. 1991; Giardiello et al., 1991; Morton et al., 1992) . Not infrequently, normal individuals have one or two areas of CHRPE (Chapman et al., 1989; Burn et al., 1991) , and therefore it is thought to be the presence of multiple areas which is of significance. The gene for FAP has been localised to 5q21 (Bodmer et al., 1987) , and a variety of polymorphic DNA markers are available (Nakamura et al., 1988; Meera Khan et al., 1988; Dunlop et al., 1990 Dunlop et al., , 1991 family syndrome. Morton et al. (1992) found CHRPE in five of ten individuals who were members of five hereditary nonpolyposis colorectal cancer families, however none of these individuals met the authors' criteria for a positive test. Sondergaard et al. (1985) identified multiple mandibular osteomata in 8 of 31 (26%) individuals with familial colorectal cancer, however these individuals were all members of two large families.
Individuals carrying the gene for familial adenomatous polyposis (FAP) can be identified by indirect ophthalmoscopy. Multiple areas of retinal hyper-and hypopigmentation, known as congenital hypertrophy of the retinal pigment epithelium (CHRPE), have been documented in 67-100% of affected patients with FAP. (Traboulsi et al.. 1987; Berk et al., 1988; Chapman et al., 1989; Burn et al.. 1991; Giardiello et al., 1991; Morton et al., 1992) . Not infrequently, normal individuals have one or two areas of CHRPE (Chapman et al., 1989; Burn et al., 1991) , and therefore it is thought to be the presence of multiple areas which is of significance. The gene for FAP has been localised to 5q21 (Bodmer et al., 1987) , and a variety of polymorphic DNA markers are available (Nakamura et al., 1988; Meera Khan et al., 1988; Dunlop et al., 1990 Dunlop et al., , 1991 , raising the possibility of exclusion of the carrier status in family members without the need for annual bowel examination (Dunlop et al., 1991) . Information from eye examination, bowel examination and DNA analysis may be combined to calculate revised risk estimates that an individual from an affected family has inherited the FAP gene.
Multiple mandibular osteomata have been found in 70%
and 76% of FAP patients (Bilow et al., 1984; Giardiello et al., 1991) . It has been suggested that a combination of the two markers may give useful additional information (Giardiello et al., 1991) . Unlike the adenomas in FAP, which tend to occur around puberty, these extracolonic lesions are present at birth or shortly afterwards, and can be detected by means of simple, cheap and relatively non-invasive examinations.
To date there has been little work assessing the incidence of CHRPE and multiple mandibular osteomata in patients with familial but non-polyposis colorectal cancer. Traboulsi et al. (1988) examined six such individuals and found no areas of CHRPE. In a small study Stephenson et al. (1992) found three out of eight (37.5%) patients with familial colorectal cancer to have multiple areas of CHRPE, and Houlston et al. (1992) family syndrome. Morton et al. (1992) found CHRPE in five of ten individuals who were members of five hereditary nonpolyposis colorectal cancer families, however none of these individuals met the authors' criteria for a positive test. Sondergaard et al. (1985) identified multiple mandibular osteomata in 8 of 31 (26%) individuals with familial colorectal cancer, however these individuals were all members of two large families.
The aim of this study was to assess the incidence of CHRPE and mandibular osteomata in patients with familial colorectal neoplasia and to compare this with the incidence in patients with sporadic colorectal neoplasia and a control population of unaffected individuals.
Patients and methods

Recruitment
Three groups of patients were recruited (Table I) .
Group I (familial colorectal neoplasia, n = 34) Forty-eight patients under follow-up by the Department of Surgery, University of Nottingham, were identified as having a firstdegree family history of colorectal cancer. They were contacted by letter and asked if they would participate in the study. Thirty-four patients agreed to do so. All these patients were under review in the colorectal cancer clinic, however on subsequent review of their histology two were found to have had large adenomas (one 3 cm villous adenoma and one 2 cm adenoma with severe dysplasia). Thirty-three patients also had a first-degree family history of colorectal cancer. On verification of the relatives' diagnoses, one individual's relative was found to have a 3 cm rectal adenoma, not a cancer. All 34 patients in the study were from different families and none was from an FAP family or had evidence of FAP.
Group 2 (sporadic colorectal neoplasia, n = 36) Patients in the sporadic colorectal neoplasia group were recruited from the same colorectal cancer clinic in the Department of Surgery. Thirty-four patients had colorectal cancer and one patient a 2 cm adenoma with severe dysplasia. None of these patients had any relatives with colorectal cancer.
Group 3 control subjects (n = 32) A mixture of spouse controls and surgical patients with no evidence of intestinal disease were recruited. These individuals were not investigated to exclude colorectal neoplasia. There were more men Br. J. Cancer (1994), 70, 173-176 (E) MacmiRan Press Ltd., 1994 (Chapman et al., 1989; Burn et al., 1991 
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Unlike results seen in FAP only one individuaL, in our study, with familial colorectal cancer had multiple mandibular osteomata (3%), a proportion which would be expected in the general population (Sondergaard et al., 1985) . There was no statisticaly significant difference in the incidence of multiple mandibular osteomata between those with familial colorectal cancer and those with sporadic diseas and control subjects. We would therefore suggest that this investigation is of no value in the management of familial non-polyposis colorectal cancer.
The finding of multiple areas of CHRPE in a considerable proportion (21%) of those with familial colorectal cancer is of great interest and has potential clinical use. Areas of CHRPE are benign and typically multiple in affected individuals. The multiplicity of the lesions and the fact that they are usually assocated with diffuse diurbances in the retinal pigment epithelium suggests widespread expression of the abnormal gene within the retinal pigment epithelial cells. Multiple areas of CHRPE have been shown to be a very accurate predictor of carriage of the FAP gene. Work from the Northern Region Polyposis Registry suggested a cut-off of two areas of hypertrophy as the upper limit of normal. This gave a false-positive rate of 0% and a false-negative rate of 7.5% of carrying the FAP gene (Chapman et al., 1989) . In subsequent work from the same department (Burn et al., 1991) In Britain, up to a quarter of all colorectal cancers are familial (Lovett, 1976; Duncan & Kyle, 1982; Stephenson et al., 1992) . In the nuclear family it is difficult to know whether a cluster of cancers is of genetic origin or the result of the shared family environment (Lynch et al., 1985) . However the finding of multiple areas of CHRPE, a lesion which appears to be independent of environmental factors, in a quarter of those with familial colorectal neoplasia suggests a constitutional genetic defect in these patients.
Our (Pe tomaki et al., 1993) . Even as the genes responsible for the various types of familial colorectal cancer are defined, inevitably, at kast for the foreseeable future, only a proportion of familes will benefit from such developments. Examination for areas of CHRPE may add to assessment of nsk in a similar manner as is currently being used in FAP, examination of the eyes being simple, cheap and relatively non-mvasive.
In addition to any possible practical applications, the identification of multiple areas of CHRPE has defined a subgroup of those patients with familial colorectal cancer who have an easily demonstrated marker. What this marker means in genetic terms is as yet unknown. It would seem more than coincidence that this is the same marker found in FAP, and it is reasonable to suppose that these individuals may have a constitutional genetic defect which is, at least in part, responsible for their cancer. It is of interest that this marker has been found not only in those from dominant pedigrees, but also in those who might previously have been thought to be at only intermediate risk of developing colorectal cancer. Undoubtedly this subgroup warrants further detailed genetic investigation.
